The hSyn mouse model thus represents a physiologically relevant platform for exploring α-Syn–tau crosstalk and for developing tau-targeted or dual-pathway therapeutic strategies for synucleinopathies and related disorders. This evidence concerns the gene RIC8B and synucleinopathy.